Published in J Am Coll Cardiol on March 20, 2002
Reduction in blood pressure with statins: results from the UCSD Statin Study, a randomized trial. Arch Intern Med (2008) 2.24
Ageing and vascular ageing. Postgrad Med J (2006) 1.36
Atorvastatin reduces arterial stiffness in patients with rheumatoid arthritis. Ann Rheum Dis (2004) 1.20
Blood pressure tracking over the adult life course: patterns and correlates in the Framingham heart study. Hypertension (2012) 1.13
Clinical appraisal of arterial stiffness: the Argonauts in front of the Golden Fleece. Heart (2005) 0.99
Early changes in arterial structure and function following statin initiation: quantification by magnetic resonance imaging. Atherosclerosis (2007) 0.97
Analysis for hypertension and related risk factors of physical examination population. Int J Clin Exp Med (2013) 0.94
Better management of cardiovascular diseases by pulse wave velocity: combining clinical practice with clinical research using evidence-based medicine. Clin Med Res (2007) 0.92
Cardiovascular adaptations to exercise training in postmenopausal women with type 2 diabetes mellitus. Cardiovasc Diabetol (2004) 0.91
Are statins effective for simultaneously treating dyslipidemias and hypertension? Atherosclerosis (2007) 0.88
Comparison of cardiovascular risk factors for high brachial pulse pressure in blacks versus whites (Charleston Heart Study, Evans County Study, NHANES I and II Studies). Am J Cardiol (2008) 0.88
Endothelial arginase II and atherosclerosis. Korean J Anesthesiol (2011) 0.87
Effects of amlodipine-atorvastatin combination on inflammation markers and insulin sensitivity in normocholesterolemic obese hypertensive patients. Eur J Clin Pharmacol (2006) 0.85
Influence of rosuvastatin on the NAD(P)H oxidase activity in the retina and electroretinographic response of spontaneously hypertensive rats. Br J Pharmacol (2007) 0.80
Antihypertensive properties of plant-based prebiotics. Int J Mol Sci (2009) 0.80
Plasma adiponectin and the risk of hypertension in white and black postmenopausal women. Clin Chem (2012) 0.79
Simvastatin induces a central hypotensive effect via Ras-mediated signalling to cause eNOS up-regulation. Br J Pharmacol (2013) 0.79
MTHFR C677T polymorphism as a risk factor for vascular calcification in chronic hemodialysis patients. J Korean Med Sci (2011) 0.79
Concomitant administration of simvastatin with ivabradine in contrast to metoprolol intensifies slowing of heart rate in normo- and hypercholesterolemic rats. Arch Med Sci (2012) 0.78
Arterial pulse wave velocity, inflammatory markers, pathological GH and IGF states, cardiovascular and cerebrovascular disease. Vasc Health Risk Manag (2008) 0.78
Effects of 4-week administration of simvastatin in different doses on heart rate and blood pressure after metoprolol injection in normocholesterolaemic and normotensive rats. Arch Med Sci (2012) 0.78
Worsened arterial stiffness in high-risk cardiovascular patients with high habitual carbohydrate intake: a cross-sectional vascular function study. BMC Cardiovasc Disord (2014) 0.77
An integrated backscatter ultrasound technique for the detection of coronary and carotid atherosclerotic lesions. Sensors (Basel) (2015) 0.77
Response to statin therapy in obstructive sleep apnea syndrome: a multicenter randomized controlled trial. Mediators Inflamm (2014) 0.77
Skeletal muscle ultrastructure and function in statin-tolerant individuals. Muscle Nerve (2015) 0.77
Add-on-Statin Extended Release Nicotinic Acid/Laropiprant but Not the Switch to High-Dose Rosuvastatin Lowers Blood Pressure: An Open-Label Randomized Study. Int J Hypertens (2011) 0.77
Impact of biological aging on arterial aging in American Indians: findings from the Strong Heart Family Study. Aging (Albany NY) (2016) 0.77
Pleiotropic and Lipid-lowering Effects of Statins in Hypertension. Mater Sociomed (2012) 0.77
Low-dose atorvastatin therapy does not augment endothelial function in active hypercholesterolaemic males. Br J Clin Pharmacol (2003) 0.75
Effect of rosuvastatin on systemic blood pressure in patients with hypercholesterolemia. Exp Clin Cardiol (2012) 0.75
Cardiovascular Responses to an Isometric Handgrip Exercise in Females with Prehypertension. N Am J Med Sci (2016) 0.75
Sustained Improvement of Arterial Stiffness and Blood Pressure after Long-Term Rosuvastatin Treatment in Patients with Inflammatory Joint Diseases: Results from the RORA-AS Study. PLoS One (2016) 0.75
Cardiovascular and inflammatory effects of simvastatin therapy in patients with COPD: a randomized controlled trial. Int J Chron Obstruct Pulmon Dis (2015) 0.75
Risk factors associated with secondary hyperparathyroidism in patients with chronic kidney disease. Exp Ther Med (2016) 0.75
Association of statin therapy with blood pressure control in hypertensive hypercholesterolemic outpatients in clinical practice. J Cardiovasc Dis Res (2011) 0.75
Effects of simvastatin on blood pressure in hypercholesterolemic patients: An open-label study in patients with hypertension or normotension. Curr Ther Res Clin Exp (2004) 0.75
The Microbiome and Blood Pressure: Can Microbes Regulate Our Blood Pressure? Front Pediatr (2017) 0.75
Retracted Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial. JAMA (2013) 4.88
Breaking up prolonged sitting reduces postprandial glucose and insulin responses. Diabetes Care (2012) 4.50
Use of arterial transfer functions for the derivation of central aortic waveform characteristics in subjects with type 2 diabetes and cardiovascular disease. Diabetes Care (2004) 3.46
Use of arterial transfer functions for the derivation of aortic waveform characteristics. J Hypertens (2003) 3.41
Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial. Lancet (2004) 3.40
Association of left ventricular motion and central augmentation index in healthy young men. J Hypertens (2012) 2.73
Coaching patients On Achieving Cardiovascular Health (COACH): a multicenter randomized trial in patients with coronary heart disease. Arch Intern Med (2003) 2.68
HSP72 protects against obesity-induced insulin resistance. Proc Natl Acad Sci U S A (2008) 2.52
Arterial pulse wave velocity but not augmentation index is associated with coronary artery disease extent and severity: implications for arterial transfer function applicability. J Hypertens (2007) 2.33
Effect of intensive structured care on individual blood pressure targets in primary care: multicentre randomised controlled trial. BMJ (2012) 2.23
Rate of morning increase in blood pressure is elevated in hypertensives. Am J Hypertens (2006) 2.15
Similar effects of treatment on central and brachial blood pressures in older hypertensive subjects in the Second Australian National Blood Pressure Trial. Hypertension (2007) 2.13
Estimation of central aortic blood pressure: a systematic meta-analysis of available techniques. J Hypertens (2014) 2.10
High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus. Circulation (2009) 2.00
Transluminal attenuation gradient in coronary computed tomography angiography is a novel noninvasive approach to the identification of functionally significant coronary artery stenosis: a comparison with fractional flow reserve. J Am Coll Cardiol (2013) 1.91
Brachial blood pressure but not carotid arterial waveforms predict cardiovascular events in elderly female hypertensives. Hypertension (2006) 1.90
Combined CT coronary angiography and stress myocardial perfusion imaging for hemodynamically significant stenoses in patients with suspected coronary artery disease: a comparison with fractional flow reserve. JACC Cardiovasc Imaging (2012) 1.87
Acute left ventricular remodeling following myocardial infarction: coupling of regional healing with remote extracellular matrix expansion. JACC Cardiovasc Imaging (2012) 1.83
Protective effects of exercise and phosphoinositide 3-kinase(p110alpha) signaling in dilated and hypertrophic cardiomyopathy. Proc Natl Acad Sci U S A (2007) 1.82
Insulin resistance and atherosclerosis. Endocr Rev (2006) 1.81
Cardiovascular magnetic resonance-derived aortic distensibility: validation and observed regional differences in the elderly. J Hypertens (2009) 1.77
Differences between pathological and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure. Clin Exp Pharmacol Physiol (2007) 1.74
Retracted Brief communication: ramipril markedly improves walking ability in patients with peripheral arterial disease: a randomized trial. Ann Intern Med (2006) 1.71
Retracted Effect of perindopril on large artery stiffness and aortic root diameter in patients with Marfan syndrome: a randomized controlled trial. JAMA (2007) 1.69
Infusion of reconstituted high-density lipoprotein leads to acute changes in human atherosclerotic plaque. Circ Res (2008) 1.65
Targeted reduction of advanced glycation improves renal function in obesity. Kidney Int (2011) 1.63
Aortic stiffness affects the coronary blood flow response to percutaneous coronary intervention. Am J Physiol Heart Circ Physiol (2005) 1.60
Low-renin hypertension with relative aldosterone excess is associated with impaired NO-mediated vasodilation. Hypertension (2005) 1.60
Relaxin therapy reverses large artery remodeling and improves arterial compliance in senescent spontaneously hypertensive rats. Hypertension (2010) 1.58
Large artery stiffness predicts ischemic threshold in patients with coronary artery disease. J Am Coll Cardiol (2002) 1.57
Arterial stiffness and prediction of cardiovascular risk. J Hypertens (2002) 1.57
Retracted Ramipril reduces large-artery stiffness in peripheral arterial disease and promotes elastogenic remodeling in cell culture. Hypertension (2005) 1.57
Matrix metalloproteinase-3 genotype contributes to age-related aortic stiffening through modulation of gene and protein expression. Circ Res (2003) 1.55
Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes. J Am Coll Cardiol (2009) 1.53
'Generalizability' of a radial-aortic transfer function for the derivation of central aortic waveform parameters. J Hypertens (2007) 1.53
Mouse model of post-infarct ventricular rupture: time course, strain- and gender-dependency, tensile strength, and histopathology. Cardiovasc Res (2005) 1.52
Pressure points in primary care: blood pressure and management of hypertension in 532 050 patients from 2005 to 2010. J Hypertens (2013) 1.49
Age and the treatment gap in the use of statins. Lancet (2003) 1.48
Coronary image quality of 320-MDCT in patients with heart rates above 65 beats per minute: preliminary experience. AJR Am J Roentgenol (2011) 1.45
Acute chest pain investigation: utility of cardiac CT angiography in guiding troponin measurement. Radiology (2011) 1.45
Plasma C-reactive protein, but not protein S, VCAM-1, von Willebrand factor or P-selectin, is associated with endothelium dysfunction in coronary artery disease. Atherosclerosis (2004) 1.43
A polymorphism in the endothelin-A receptor gene is linked to baroreflex sensitivity. J Hypertens (2005) 1.42
Pre-hospital 12 lead ECG to triage ST elevation myocardial infarction and long term improvements in door to balloon times: The first 1000 patients from the MonAMI project. Heart Lung Circ (2013) 1.41
Reconstituted high-density lipoprotein attenuates platelet function in individuals with type 2 diabetes mellitus by promoting cholesterol efflux. Circulation (2009) 1.40
Intravascular ultrasound guidance improves clinical outcomes during implantation of both first and second-generation drug-eluting stents: a meta-analysis. EuroIntervention (2016) 1.40
Plasma lipidomic analysis of stable and unstable coronary artery disease. Arterioscler Thromb Vasc Biol (2011) 1.39
Ceramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance. Diabetes (2012) 1.38
Selective drug-eluting stent implantation for high-risk patients with acute ST-elevation myocardial infarction: rationale and safety. Catheter Cardiovasc Interv (2011) 1.38
Stress thallium-201/rest technetium-99m sequential dual-isotope high-speed myocardial perfusion imaging validation versus invasive coronary angiography. J Nucl Cardiol (2014) 1.38
Gender, sex hormones and autonomic nervous control of the cardiovascular system. Cardiovasc Res (2002) 1.38
Optimizing dosage of ketamine and xylazine in murine echocardiography. Clin Exp Pharmacol Physiol (2007) 1.31
Computed tomography stress myocardial perfusion imaging in patients considered for revascularization: a comparison with fractional flow reserve. Eur Heart J (2011) 1.31
Cardiovascular effects of relaxin: from basic science to clinical therapy. Nat Rev Cardiol (2009) 1.26
Differences in inflammation, MMP activation and collagen damage account for gender difference in murine cardiac rupture following myocardial infarction. J Mol Cell Cardiol (2007) 1.25
Effects of breaking up prolonged sitting on skeletal muscle gene expression. J Appl Physiol (1985) (2012) 1.24
High-density lipoprotein and apolipoprotein AI increase endothelial NO synthase activity by protein association and multisite phosphorylation. Proc Natl Acad Sci U S A (2004) 1.23
Matrix metalloproteinase-9 genotype influences large artery stiffness through effects on aortic gene and protein expression. Arterioscler Thromb Vasc Biol (2004) 1.23
Deletion of macrophage migration inhibitory factor protects the heart from severe ischemia-reperfusion injury: a predominant role of anti-inflammation. J Mol Cell Cardiol (2011) 1.22
Acute and chronic effects of flavanol-rich cocoa on vascular function in subjects with coronary artery disease: a randomized double-blind placebo-controlled study. Clin Sci (Lond) (2006) 1.22
Gender differences in artery wall biomechanical properties throughout life. J Hypertens (2011) 1.21
Association of carotid intima-medial thickness and indices of arterial stiffness with cardiovascular disease outcomes in CKD. Am J Kidney Dis (2007) 1.20
Gender differences in large artery stiffness pre- and post puberty. J Clin Endocrinol Metab (2003) 1.20
The emerging role of HDL in glucose metabolism. Nat Rev Endocrinol (2012) 1.17
Novel role of platelets in mediating inflammatory responses and ventricular rupture or remodeling following myocardial infarction. Arterioscler Thromb Vasc Biol (2011) 1.15
Advanced glycation end products are direct modulators of β-cell function. Diabetes (2011) 1.14
Down-regulation of mitofusin-2 expression in cardiac hypertrophy in vitro and in vivo. Life Sci (2007) 1.13
Transgenic alpha1A-adrenergic activation limits post-infarct ventricular remodeling and dysfunction and improves survival. Cardiovasc Res (2006) 1.11
Phosphoinositide 3-kinase as a novel functional target for the regulation of the insulin signaling pathway by SIRT1. Mol Cell Endocrinol (2011) 1.11
Skeletal muscle nNOS mu protein content is increased by exercise training in humans. Am J Physiol Regul Integr Comp Physiol (2007) 1.10
Mechanism of cholesterol efflux in humans after infusion of reconstituted high-density lipoprotein. Eur Heart J (2011) 1.10
Influence of atrial fibrillation on microRNA expression profiles in left and right atria from patients with valvular heart disease. Physiol Genomics (2011) 1.10
Alternating bouts of sitting and standing attenuate postprandial glucose responses. Med Sci Sports Exerc (2014) 1.08
Sex steroids modulate human aortic smooth muscle cell matrix protein deposition and matrix metalloproteinase expression. Hypertension (2005) 1.08
Pathophysiological levels of soluble P-selectin mediate adhesion of leukocytes to the endothelium through Mac-1 activation. Circ Res (2008) 1.08
Reduced phosphoinositide 3-kinase (p110alpha) activation increases the susceptibility to atrial fibrillation. Am J Pathol (2009) 1.07
Misclassification of studies in 'Brachial artery tonometry and the Popeye phenomenon'. J Hypertens (2013) 1.07
Smaller aortic dimensions do not fully account for the greater pulse pressure in elderly female hypertensives. Hypertension (2008) 1.05
Fibrillin-1 genotype is associated with aortic stiffness and disease severity in patients with coronary artery disease. Circulation (2002) 1.05
Infarct size and post-infarct inflammation determine the risk of cardiac rupture in mice. Int J Cardiol (2009) 1.03
Accuracy of automated auscultatory blood pressure measurement during supine exercise and treadmill stress electrocardiogram-testing. Blood Press Monit (2004) 1.02
Physical fitness and reverse cholesterol transport. Arterioscler Thromb Vasc Biol (2004) 1.02
Usefulness of cooling and coronary catheterization to improve survival in out-of-hospital cardiac arrest. Am J Cardiol (2010) 1.01
Arterial transfer functions and the reconstruction of central aortic waveforms: myths, controversies and misconceptions. J Hypertens (2008) 1.01
Sex hormones and cardiomyopathic phenotype induced by cardiac beta 2-adrenergic receptor overexpression. Endocrinology (2003) 1.00